shutterstock_1297312387_andrii_yalanskyi
Andrii Yalanskyi / Shutterstock.com
2 July 2019Big Pharma

Reddie & Grose adds new partner in Munich

Reddie & Grose has appointed Robin Ellis as a partner in the firm’s Munich office.

Ellis rejoins the firm, where he was previously worked as a patent attorney from 2001 to 2006, from German pharmaceutical company and Novartis subsidiary Sandoz.

He had served as head of the 25-attorney team working on small molecule patents at Sandoz since January 2017.

He was previously head of respiratory patents at the German company.

Ellis will be the first partner based permanently in Reddie & Grose’s Munich office.

His work at Sandoz focused on contentious IP matters including freedom to operate assessments, due diligence, licensing negotiations and oppositions at the European Patent Office.

Jan Vleck, managing director at Reddie & Grose, said the firm was “delighted to welcome Robin at a time when the firm is investing in life sciences and growing the team in continental Europe”.

Did you enjoy reading this story?  Sign up to our free newsletters and get stories like this sent straight to your inbox.


More on this story

Big Pharma
27 June 2023   UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.

More on this story

Big Pharma
27 June 2023   UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.